MoonLake Immunotherapeutics (MLTX) - News Mentions

Sign up to add (MLTX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 2 0%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of “Moderate Buy” by Analysts
July 30
MoonLake Immunotherapeutics (NASDAQ:MLTX) Coverage Initiated at Rothschild & Co Redburn
July 29
MoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to “Hold” at Redburn Atlantic
July 29
MoonLake Immunotherapeutics Sees Unusually High Options Volume (NASDAQ:MLTX)
July 26
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Consensus Rating of “Buy” by Analysts
July 5
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of “Buy” from Analysts
July 5
MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 2.7% – Still a Buy?
July 3
MoonLake Immunotherapeutics (NASDAQ:MLTX) versus DURECT (NASDAQ:DRRX) Financial Analysis
June 14
Analysts Set MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target at $78.71
June 13
Cantor Fitzgerald Weighs in on MLTX FY2026 Earnings
June 11
MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns “Outperform” Rating from Royal Bank of Canada
June 4
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
June 4
Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 20,141 MoonLake Immunotherapeutics (NASDAQ:MLTX)
June 4
MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover
June 3
MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest
June 3
HC Wainwright Issues Optimistic Estimate for MLTX Earnings
May 30

Month over Month

Est. daily news mentions.

Jul 2025 0
Jun 2025 0
May 2025 0
Apr 2025 0
Mar 2025 0

How often is MoonLake Immunotherapeutics mentioned in the news?

MoonLake Immunotherapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is MoonLake Immunotherapeutics performing compared to its industry peers?

MoonLake Immunotherapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of MoonLake Immunotherapeutics in the last month?

MoonLake Immunotherapeutics' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for MoonLake Immunotherapeutics?

By monitoring mentions in the news for MoonLake Immunotherapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of MoonLake Immunotherapeutics, ultimately improving their investment strategies.

Sign up and get more insights on MoonLake Immunotherapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.